SPOTLIGHT -
Repository corticotropin injections: Relief for refractory severe noninfectious keratitis
Joseph Grieco, PhD, notes that treatment fills a gap for patients who are unresponsive to the standard treatments for noninfectious keratitis.
Read More
Eliminating the potential land mines in glaucoma surgery
Ophthalmologist details his preferred technique to avoid complications during procedure.
Diabetes and DR: Progress in the global epidemic
According to Lloyd Paul Aiello, MD, PhD, a key hurdle for diabetic retinopathy is the lack of patient awareness, which is a substantial contributor to non-adherence to eye care guidelines and poor outcomes.
Expansion study examines safety, efficacy of subretinal gene therapy for X-linked RP
Investigators use an adeno-associated viral vector in a clinical trial to deliver a normal functioning copy of the RPGR gene via subretinal injection.
Unplugging the clogged drain in glaucoma
IOP-controlling protein in the trabecular meshwork may get the fluid moving.
Non-viral gene therapy eases treatment burden in wet AMD
A non-viral gene therapy sustained drug-delivery product that delivers anti-VEGF to the eye may replace the need for repeated intravitreal anti-VEGF injections and improve vision in patients diagnosed with wet AMD.
Novel factors predictive of ocriplasmin efficacy in symptomatic vitreomacular traction
Logan Vander Woude, DO, MPH, examines research on improved resolution of symptomatic vitreomacular traction as an attempt to further refine the potential factors predictive of better outcomes.
TENAYA, LUCERNE trials show faricimab hits primary endpoints
Robyn Guymer, PhD, MBBS, highlights the latest trial results for faricimab, the first bispecific antibody designed for intraocular use in treating patients with neovascular age-related macular degeneration.
Patient-based research powers the revealing of disease mechanisms
Approach can unravel causes in MYOC and TBK1 glaucoma.
Barriers to timely diagnosis of central retinal arterial occlusions can create hurdles
Bryce Buchowicz, MD, outlines roadblocks to timely diagnosis of central retinal artery occlusion and treatment with tissue plasminogen activator.
Study outlines use of intravitreal injection of allogeneic human retinal progenitor cells to treat RP
During ARVO 2021, Sunil Srivastava, MD, points out that optical coherence tomography characteristics may be predictive of the efficacy of the injections.
Favorable 1-year results of faricimab for treating DME
At ARVO’s 2021 virtual annual meeting, John Wells, MD, presents efficacy, durability, and safety findings from the phase 3 YOSEMITE and RHINE trials.
Investigators study impact of anti-VEGF treatment lapses in retinal vein occlusion
According to Jessica Liu, patients with BRVO or CRVO with any lapse in treatment of 3 months or longer are at risk for poorer outcomes.
Ocular blood flow reflects systemic organ blood flow in hemorrhagic shock
Investigators found that non-invasive ocular blood flow measurement using laser speckle flowgraphy may be a new indicator of shock-related organ damage.
Treatment device changes paradigm in MGD care
Investigators review changes in ocular anterior segment blood flow and temperature after treatment of patients with meibomian gland dysfunction.
Phaco power modulation boosts safety, efficacy in cataract surgery
Surgeons learn that timing is everything when using technology.
Shedding light on Horner syndrome
Clues to dangerous etiologies include pain and positive imaging findings.
Sorting out intravitreal brolucizumab's inflammation issue
Preexisting neutralizing antibodies associated with the inflammatory changes.
Seeking a new frontier with intraoperative OCT
Advances in integrative technology enable a transition to the operating room.
AI enhances customized myopic LASIK with ray tracing optimization
Novel technique provides another option for normal and irregular corneas.
IRISS registry study offers real-world outcomes
Fluocinolone acetonide implant for DME benefits visual acuity.
New options continue to fill sustained drug delivery pipeline
Injections, implants continue to create further positive outcomes for patients.
Intracanalicular dexamethasone insert offers hands-free therapy
An alternative to drops, the option provides consistent therapeutic levels.
SMILE offers low enhancement rate after nomogram adjustment
Refractive surgery for treating myopia is linked to low rates of regression, enhancement.
Regeneration may help restore vision in inherited retinal dystrophies
Studying zebrafish helps unravel mysteries of photoreceptor regeneration .
Curvature-changing IOL: New frontier in cataract and presbyopia surgeries
Lens offers full range of vision from distance through near vision.
Retinal therapeutic clinical trials address disease at core
Studies are uncovering a range of potential treatment options for disorders.
Light-adjustable IOL offers positive refractive results in patients
New option may prove to be a solution for cataract cases with unusual corneas.
Raising the retinal disease treatment bar with genetic testing
Options for physicians are increasing in availability with fewer burdens for patients.
AAO’s Truhlsen-Marmor Museum offering spring viral programs
The American Academy of Ophthalmology’s Truhlsen-Marmor Museum of the Eye is offering a free 2-part virtual series that will provide attendees an idea what is going on inside of their very own eyes and gut.